Ask AI
Latest Advances in HS care

CME

Expert Insights on the Latest Advances in HS Care

Physicians: Maximum of 0.25 AMA PRA Category 1 Credit

Released: May 19, 2026

Expiration: May 18, 2027

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

A 35-year-old man with Hurley stage II HS continues to experience recurrent abscesses, inflammatory nodules, and impaired quality of life despite oral antibiotics and prior TNF inhibitor therapy. His healthcare professional discusses emerging and recently available targeted therapies supported by phase III clinical trial data. The patient prefers a treatment option associated with clinically meaningful improvement and manageable tolerability.

Which of the following therapeutic approaches has demonstrated efficacy in moderate to severe HS in recent clinical trials?